Skip to main content
logo
Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
319.57
+13.95 (4.56%)
At close: Feb 6, 2026, 4:00 PM EST
319.70
+0.13 (0.04%)
After-hours: Feb 6, 2026, 7:53 PM EST

PRAX Revenue

Praxis Precision Medicines had revenue of $7.46M in the twelve months ending September 30, 2025, up 364.98% year-over-year. In the year 2024, Praxis Precision Medicines had annual revenue of $8.55M with 249.53% growth.

Revenue (ttm)
$7.46M
Revenue Growth
+364.98%
P/S Ratio
1,187.80
Revenue / Employee
$64,336
Employees
116
Market Cap
8.86B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20248.55M6.11M249.53%
Dec 31, 20232.45M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Jazz Pharmaceuticals4.16B
Halozyme Therapeutics1.24B
Bio-Techne1.22B
Arrowhead Pharmaceuticals1.09B
Madrigal Pharmaceuticals740.64M
Axsome Therapeutics561.26M
Krystal Biotech373.16M
Cytokinetics87.21M
Revenue Rankings

PRAX News

More News